ROCKWELL MEDICAL, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
ROCKWELL MEDICAL, INC. (RMTI) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $552.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $552.00K.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $166.00K.
- 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $167.00K.
- 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $167.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $552.00K 10-K · filed 2026-03-26 |
| 2015-12-31 | $166.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | $167.00K 10-K · filed 2015-03-03 |
| 2013-12-31 | $167.00K 10-K · filed 2014-03-07 |
| 2012-12-31 | $167.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |